Equities researchers at Aegis initiated coverage on shares of Xtant Medical Holdings Inc (NASDAQ:XTNT) in a research report issued on Wednesday, The Fly reports. The brokerage set a “buy” rating on the stock.

Other equities analysts also recently issued reports about the stock. HC Wainwright reissued a “buy” rating on shares of Xtant Medical Holdings in a report on Thursday, August 4th. Zacks Investment Research raised shares of Xtant Medical Holdings from a “hold” rating to a “buy” rating and set a $0.75 price target on the stock in a report on Saturday, November 12th.

Shares of Xtant Medical Holdings (NASDAQ:XTNT) opened at 0.4935 on Wednesday. The stock has a 50 day moving average of $0.76 and a 200-day moving average of $1.44. The firm’s market capitalization is $6.02 million. Xtant Medical Holdings has a 1-year low of $0.45 and a 1-year high of $3.75.

ILLEGAL ACTIVITY WARNING: “Aegis Initiates Coverage on Xtant Medical Holdings Inc (XTNT)” was originally published by Financial Market News and is the propert of of Financial Market News. If you are accessing this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The legal version of this news story can be viewed at http://www.financial-market-news.com/aegis-initiates-coverage-on-xtant-medical-holdings-inc-xtnt/1210294/.

Xtant Medical Holdings Company Profile

Xtant Medical Holdings, Inc, formerly Bacterin International Holdings, Inc, develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment.

5 Day Chart for NASDAQ:XTNT

The Fly

Receive News & Ratings for Xtant Medical Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.